Jill Norris
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoimmunity | 74 | 2023 | 818 | 9.720 |
Why?
| Diabetes Mellitus, Type 1 | 114 | 2023 | 3245 | 8.460 |
Why?
| Islets of Langerhans | 56 | 2023 | 729 | 7.800 |
Why?
| Autoantibodies | 90 | 2023 | 1354 | 7.080 |
Why?
| Arthritis, Rheumatoid | 47 | 2024 | 1002 | 6.960 |
Why?
| Diet | 27 | 2024 | 1076 | 4.340 |
Why?
| Vitamin D | 21 | 2022 | 340 | 4.210 |
Why?
| Rheumatoid Factor | 22 | 2024 | 157 | 3.850 |
Why?
| Fatty Acids, Omega-3 | 13 | 2020 | 124 | 3.790 |
Why?
| Celiac Disease | 20 | 2022 | 264 | 3.280 |
Why?
| Anti-Citrullinated Protein Antibodies | 11 | 2023 | 90 | 3.250 |
Why?
| Genetic Predisposition to Disease | 67 | 2023 | 2108 | 3.110 |
Why?
| Risk Factors | 103 | 2023 | 8642 | 2.600 |
Why?
| Polymorphism, Single Nucleotide | 59 | 2023 | 1901 | 2.530 |
Why?
| Glutens | 9 | 2021 | 56 | 2.340 |
Why?
| Lupus Erythematosus, Systemic | 8 | 2022 | 221 | 2.330 |
Why?
| Peptides, Cyclic | 21 | 2023 | 254 | 2.270 |
Why?
| Erythrocyte Membrane | 6 | 2015 | 50 | 2.220 |
Why?
| Child, Preschool | 97 | 2023 | 9093 | 2.200 |
Why?
| Infant | 98 | 2023 | 7945 | 2.130 |
Why?
| Genome-Wide Association Study | 26 | 2023 | 1203 | 2.080 |
Why?
| Breast Feeding | 21 | 2021 | 367 | 2.070 |
Why?
| Female | 243 | 2023 | 59610 | 2.040 |
Why?
| Insulin Resistance | 43 | 2023 | 1077 | 2.030 |
Why?
| Prospective Studies | 65 | 2023 | 6232 | 2.020 |
Why?
| Male | 229 | 2023 | 55729 | 1.990 |
Why?
| Humans | 322 | 2024 | 115038 | 1.820 |
Why?
| Child | 111 | 2023 | 18407 | 1.800 |
Why?
| DNA Methylation | 4 | 2021 | 496 | 1.760 |
Why?
| Diabetes Mellitus, Type 2 | 34 | 2023 | 2098 | 1.750 |
Why?
| Family | 22 | 2023 | 591 | 1.750 |
Why?
| Adiposity | 19 | 2017 | 466 | 1.710 |
Why?
| Disease Progression | 29 | 2022 | 2389 | 1.670 |
Why?
| Oxylipins | 3 | 2023 | 27 | 1.670 |
Why?
| Vitamin D Deficiency | 6 | 2018 | 158 | 1.580 |
Why?
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 133 | 1.510 |
Why?
| Milk | 11 | 2018 | 124 | 1.500 |
Why?
| Genotype | 50 | 2023 | 1780 | 1.420 |
Why?
| Infant Food | 9 | 2018 | 63 | 1.420 |
Why?
| Cohort Studies | 53 | 2022 | 4904 | 1.300 |
Why?
| Follow-Up Studies | 41 | 2021 | 4420 | 1.290 |
Why?
| Insulin | 27 | 2021 | 2082 | 1.260 |
Why?
| Adiponectin | 11 | 2018 | 212 | 1.250 |
Why?
| Fatty Acids, Unsaturated | 3 | 2021 | 85 | 1.230 |
Why?
| Atherosclerosis | 18 | 2023 | 342 | 1.220 |
Why?
| Middle Aged | 106 | 2021 | 26826 | 1.220 |
Why?
| Proportional Hazards Models | 19 | 2021 | 1080 | 1.210 |
Why?
| Eating | 6 | 2023 | 347 | 1.170 |
Why?
| Body Mass Index | 32 | 2023 | 1967 | 1.170 |
Why?
| HLA-DR Antigens | 15 | 2017 | 220 | 1.160 |
Why?
| Case-Control Studies | 33 | 2023 | 3015 | 1.160 |
Why?
| HLA-DR4 Antigen | 11 | 2021 | 76 | 1.140 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2023 | 450 | 1.120 |
Why?
| Dietary Proteins | 6 | 2019 | 123 | 1.100 |
Why?
| Adult | 115 | 2021 | 30654 | 1.100 |
Why?
| Dietary Sucrose | 2 | 2020 | 45 | 1.060 |
Why?
| Biomarkers | 25 | 2024 | 3419 | 1.040 |
Why?
| Infant, Newborn | 48 | 2022 | 5040 | 1.000 |
Why?
| Seroconversion | 2 | 2021 | 46 | 0.910 |
Why?
| Obesity | 21 | 2021 | 2524 | 0.900 |
Why?
| Metabolic Syndrome | 6 | 2021 | 324 | 0.870 |
Why?
| Colorado | 36 | 2020 | 4089 | 0.870 |
Why?
| Docosahexaenoic Acids | 5 | 2021 | 69 | 0.860 |
Why?
| Longitudinal Studies | 19 | 2020 | 2389 | 0.850 |
Why?
| Edible Grain | 5 | 2013 | 43 | 0.840 |
Why?
| Incidence | 21 | 2023 | 2318 | 0.830 |
Why?
| Infant Formula | 5 | 2019 | 74 | 0.810 |
Why?
| Autoimmune Diseases | 8 | 2019 | 394 | 0.790 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 97 | 0.780 |
Why?
| HLA-DR3 Antigen | 9 | 2023 | 79 | 0.780 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.770 |
Why?
| Blood Glucose | 16 | 2018 | 1821 | 0.770 |
Why?
| Epitopes | 5 | 2022 | 436 | 0.750 |
Why?
| Environmental Exposure | 4 | 2020 | 377 | 0.750 |
Why?
| Surveys and Questionnaires | 21 | 2022 | 4631 | 0.750 |
Why?
| Mass Screening | 8 | 2021 | 1012 | 0.750 |
Why?
| Metabolomics | 5 | 2023 | 527 | 0.740 |
Why?
| Adolescent | 57 | 2023 | 17862 | 0.740 |
Why?
| Transglutaminases | 11 | 2021 | 142 | 0.740 |
Why?
| F2-Isoprostanes | 2 | 2015 | 14 | 0.730 |
Why?
| Overweight | 6 | 2021 | 474 | 0.730 |
Why?
| HLA-DQ Antigens | 14 | 2018 | 177 | 0.710 |
Why?
| Fatty Acids, Omega-6 | 5 | 2020 | 46 | 0.710 |
Why?
| Pregnancy | 26 | 2023 | 5519 | 0.700 |
Why?
| Mexican Americans | 5 | 2019 | 101 | 0.700 |
Why?
| Sugars | 1 | 2020 | 29 | 0.700 |
Why?
| Inflammation Mediators | 4 | 2020 | 476 | 0.690 |
Why?
| Receptors, Calcitriol | 4 | 2016 | 53 | 0.690 |
Why?
| Age Factors | 25 | 2019 | 2894 | 0.680 |
Why?
| Phospholipids | 1 | 2021 | 199 | 0.680 |
Why?
| Phenotype | 27 | 2021 | 2815 | 0.650 |
Why?
| Genetic Variation | 8 | 2017 | 876 | 0.650 |
Why?
| Immunoglobulin G | 8 | 2023 | 776 | 0.640 |
Why?
| Genome, Human | 8 | 2017 | 351 | 0.630 |
Why?
| Gene Frequency | 16 | 2021 | 483 | 0.620 |
Why?
| Immunoglobulin A | 9 | 2023 | 171 | 0.620 |
Why?
| Aged | 47 | 2021 | 19119 | 0.620 |
Why?
| Milk Proteins | 3 | 2008 | 36 | 0.620 |
Why?
| Polymorphism, Genetic | 11 | 2021 | 617 | 0.620 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2018 | 45 | 0.610 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 141 | 0.600 |
Why?
| Family Health | 11 | 2017 | 194 | 0.590 |
Why?
| HLA Antigens | 14 | 2019 | 224 | 0.580 |
Why?
| Alleles | 13 | 2021 | 792 | 0.580 |
Why?
| Glutamate Decarboxylase | 12 | 2021 | 160 | 0.580 |
Why?
| Genetic Linkage | 11 | 2016 | 297 | 0.570 |
Why?
| Genetic Loci | 8 | 2020 | 264 | 0.560 |
Why?
| Cytokines | 7 | 2020 | 1843 | 0.560 |
Why?
| Air Pollution | 2 | 2024 | 170 | 0.560 |
Why?
| PPAR gamma | 3 | 2016 | 184 | 0.550 |
Why?
| Dietary Supplements | 7 | 2019 | 458 | 0.550 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 14 | 0.540 |
Why?
| Arachidonic Acid | 2 | 2021 | 117 | 0.540 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 136 | 0.540 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 46 | 0.540 |
Why?
| Homeostasis | 15 | 2023 | 578 | 0.530 |
Why?
| Sputum | 4 | 2021 | 285 | 0.530 |
Why?
| Carbohydrates | 2 | 2015 | 56 | 0.530 |
Why?
| Diet Surveys | 7 | 2021 | 78 | 0.530 |
Why?
| Non-alcoholic Fatty Liver Disease | 6 | 2023 | 246 | 0.520 |
Why?
| Diabetes, Gestational | 7 | 2020 | 281 | 0.520 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.510 |
Why?
| Population Surveillance | 4 | 2015 | 392 | 0.510 |
Why?
| Feeding Behavior | 4 | 2018 | 574 | 0.510 |
Why?
| Child Day Care Centers | 1 | 2015 | 33 | 0.490 |
Why?
| Altitude | 1 | 2018 | 434 | 0.480 |
Why?
| Joints | 3 | 2013 | 84 | 0.470 |
Why?
| Micronutrients | 3 | 2017 | 77 | 0.470 |
Why?
| Glucose | 11 | 2023 | 900 | 0.470 |
Why?
| Blood Pressure | 8 | 2020 | 1539 | 0.470 |
Why?
| Chemokines | 2 | 2012 | 213 | 0.460 |
Why?
| Pedigree | 11 | 2020 | 467 | 0.460 |
Why?
| Intra-Abdominal Fat | 10 | 2021 | 83 | 0.460 |
Why?
| Dietary Fats, Unsaturated | 3 | 2011 | 21 | 0.450 |
Why?
| Tobacco Smoke Pollution | 3 | 2007 | 217 | 0.450 |
Why?
| Energy Intake | 7 | 2023 | 421 | 0.450 |
Why?
| Stress, Psychological | 2 | 2020 | 946 | 0.450 |
Why?
| Diet Records | 5 | 2019 | 76 | 0.440 |
Why?
| Dietary Fats | 3 | 2011 | 290 | 0.440 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 30 | 0.440 |
Why?
| GTP-Binding Proteins | 5 | 2021 | 141 | 0.440 |
Why?
| Pediatrics | 2 | 2020 | 981 | 0.430 |
Why?
| Genetic Association Studies | 7 | 2020 | 344 | 0.430 |
Why?
| Bacteroidaceae Infections | 1 | 2012 | 4 | 0.430 |
Why?
| Smoking | 9 | 2019 | 1392 | 0.420 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 17 | 0.420 |
Why?
| Cross-Sectional Studies | 12 | 2022 | 4411 | 0.420 |
Why?
| Pregnancy in Diabetics | 3 | 2012 | 82 | 0.420 |
Why?
| United States | 38 | 2022 | 12224 | 0.420 |
Why?
| Multivariate Analysis | 12 | 2021 | 1435 | 0.420 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.420 |
Why?
| C-Reactive Protein | 6 | 2018 | 363 | 0.410 |
Why?
| Periodontitis | 1 | 2012 | 42 | 0.410 |
Why?
| Ascorbic Acid | 3 | 2023 | 110 | 0.410 |
Why?
| Risk Assessment | 12 | 2020 | 2976 | 0.410 |
Why?
| Fluorocarbons | 2 | 2023 | 94 | 0.400 |
Why?
| Antibodies, Bacterial | 1 | 2012 | 119 | 0.400 |
Why?
| Exome | 4 | 2021 | 201 | 0.390 |
Why?
| Age of Onset | 9 | 2018 | 449 | 0.390 |
Why?
| Calcifediol | 1 | 2011 | 29 | 0.390 |
Why?
| Texas | 8 | 2014 | 187 | 0.380 |
Why?
| Genetic Testing | 7 | 2020 | 380 | 0.380 |
Why?
| Logistic Models | 10 | 2019 | 1839 | 0.380 |
Why?
| RGS Proteins | 1 | 2011 | 12 | 0.370 |
Why?
| Fetal Blood | 5 | 2021 | 270 | 0.370 |
Why?
| Waist-Hip Ratio | 3 | 2007 | 30 | 0.370 |
Why?
| Extracellular Traps | 3 | 2021 | 40 | 0.370 |
Why?
| Europe | 12 | 2020 | 336 | 0.370 |
Why?
| Quantitative Trait, Heritable | 2 | 2017 | 117 | 0.370 |
Why?
| Food, Fortified | 1 | 2010 | 37 | 0.360 |
Why?
| Quantitative Trait Loci | 8 | 2020 | 309 | 0.360 |
Why?
| Epigenesis, Genetic | 3 | 2021 | 524 | 0.350 |
Why?
| Diabetes Mellitus | 6 | 2020 | 906 | 0.350 |
Why?
| Membrane Proteins | 6 | 2019 | 1019 | 0.350 |
Why?
| Exercise | 4 | 2021 | 1644 | 0.340 |
Why?
| Air Pollutants | 2 | 2024 | 244 | 0.340 |
Why?
| Food Preferences | 1 | 2011 | 108 | 0.340 |
Why?
| Enzyme-Linked Immunosorbent Assay | 7 | 2019 | 797 | 0.340 |
Why?
| Triglycerides | 5 | 2021 | 471 | 0.330 |
Why?
| Body Height | 2 | 2009 | 180 | 0.330 |
Why?
| Cholesterol, HDL | 4 | 2019 | 184 | 0.320 |
Why?
| Adipose Tissue | 7 | 2017 | 558 | 0.320 |
Why?
| HLA-DQ beta-Chains | 7 | 2015 | 59 | 0.320 |
Why?
| Life Style | 5 | 2015 | 431 | 0.320 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2021 | 744 | 0.310 |
Why?
| Glycemic Index | 1 | 2008 | 21 | 0.310 |
Why?
| Inflammation | 5 | 2022 | 2485 | 0.310 |
Why?
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 57 | 0.310 |
Why?
| Vaccines | 2 | 2023 | 376 | 0.300 |
Why?
| Prognosis | 9 | 2021 | 3334 | 0.300 |
Why?
| Vitamins | 3 | 2024 | 151 | 0.300 |
Why?
| Calcitriol | 1 | 2008 | 53 | 0.300 |
Why?
| Odds Ratio | 7 | 2019 | 957 | 0.300 |
Why?
| Environmental Pollutants | 2 | 2024 | 110 | 0.290 |
Why?
| Lipid Metabolism | 3 | 2019 | 449 | 0.290 |
Why?
| Probiotics | 2 | 2019 | 46 | 0.290 |
Why?
| Lipase | 3 | 2019 | 57 | 0.280 |
Why?
| Psychology, Child | 1 | 2007 | 37 | 0.280 |
Why?
| Bias | 3 | 2021 | 179 | 0.280 |
Why?
| Young Adult | 21 | 2021 | 10498 | 0.280 |
Why?
| Precision Medicine | 2 | 2020 | 340 | 0.280 |
Why?
| Fetal Distress | 1 | 2006 | 12 | 0.280 |
Why?
| Linkage Disequilibrium | 5 | 2011 | 245 | 0.280 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.270 |
Why?
| Heat-Shock Proteins | 1 | 2007 | 113 | 0.270 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 23 | 0.270 |
Why?
| Abdominal Fat | 6 | 2017 | 43 | 0.270 |
Why?
| Immunoglobulin M | 5 | 2022 | 251 | 0.270 |
Why?
| Insulin Antibodies | 6 | 2016 | 102 | 0.270 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 64 | 0.260 |
Why?
| Vitamin D-Binding Protein | 3 | 2021 | 13 | 0.260 |
Why?
| C-Peptide | 4 | 2017 | 138 | 0.260 |
Why?
| Nutritional Status | 2 | 2013 | 287 | 0.260 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1138 | 0.260 |
Why?
| Genetic Markers | 6 | 2013 | 323 | 0.260 |
Why?
| Protective Factors | 2 | 2016 | 87 | 0.250 |
Why?
| Autoantigens | 5 | 2021 | 397 | 0.250 |
Why?
| Sex Factors | 9 | 2019 | 1721 | 0.250 |
Why?
| Risk | 8 | 2019 | 815 | 0.250 |
Why?
| Insulin-Secreting Cells | 3 | 2018 | 318 | 0.250 |
Why?
| Hypertension | 5 | 2020 | 1058 | 0.250 |
Why?
| Animals | 19 | 2022 | 31867 | 0.250 |
Why?
| Infant, Newborn, Diseases | 1 | 2006 | 104 | 0.240 |
Why?
| Cattle | 6 | 2017 | 924 | 0.240 |
Why?
| Rubella | 2 | 2023 | 19 | 0.240 |
Why?
| Time Factors | 15 | 2017 | 6141 | 0.240 |
Why?
| CpG Islands | 2 | 2021 | 118 | 0.240 |
Why?
| Fatty Acids | 2 | 2021 | 385 | 0.240 |
Why?
| Chromosomes, Human, Pair 17 | 5 | 2008 | 57 | 0.240 |
Why?
| Body Composition | 5 | 2017 | 586 | 0.240 |
Why?
| Glucose Tolerance Test | 10 | 2018 | 344 | 0.230 |
Why?
| Fasting | 7 | 2015 | 242 | 0.230 |
Why?
| Alanine Transaminase | 3 | 2021 | 140 | 0.230 |
Why?
| Disease Susceptibility | 4 | 2020 | 316 | 0.230 |
Why?
| Erythrocytes | 2 | 2021 | 591 | 0.230 |
Why?
| Bottle Feeding | 2 | 2018 | 20 | 0.220 |
Why?
| Intestinal Mucosa | 1 | 2008 | 528 | 0.220 |
Why?
| Lipids | 4 | 2019 | 586 | 0.220 |
Why?
| Birth Weight | 3 | 2018 | 440 | 0.220 |
Why?
| Data Accuracy | 1 | 2024 | 48 | 0.220 |
Why?
| Mumps | 1 | 2023 | 23 | 0.220 |
Why?
| Interleukin-6 | 2 | 2021 | 676 | 0.220 |
Why?
| Seizures | 1 | 2006 | 341 | 0.220 |
Why?
| Arteriosclerosis | 6 | 2005 | 82 | 0.220 |
Why?
| Iron Overload | 1 | 2023 | 10 | 0.220 |
Why?
| Measles | 1 | 2023 | 38 | 0.220 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2016 | 16 | 0.210 |
Why?
| Chromosome Mapping | 11 | 2009 | 490 | 0.210 |
Why?
| Pediatric Obesity | 3 | 2018 | 492 | 0.210 |
Why?
| Protein-Arginine Deiminases | 3 | 2021 | 16 | 0.210 |
Why?
| Chickenpox | 1 | 2023 | 93 | 0.210 |
Why?
| Seroepidemiologic Studies | 3 | 2012 | 138 | 0.200 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2021 | 58 | 0.200 |
Why?
| Nuclear Family | 3 | 2019 | 49 | 0.200 |
Why?
| Urine | 1 | 2002 | 55 | 0.200 |
Why?
| Citrullination | 2 | 2020 | 12 | 0.200 |
Why?
| Propensity Score | 1 | 2023 | 224 | 0.200 |
Why?
| Cotinine | 1 | 2002 | 67 | 0.200 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 413 | 0.190 |
Why?
| Citrulline | 2 | 2016 | 39 | 0.190 |
Why?
| Aspartate Aminotransferases | 2 | 2019 | 86 | 0.190 |
Why?
| Sulfates | 1 | 2021 | 43 | 0.190 |
Why?
| Antibodies, Viral | 3 | 2019 | 522 | 0.190 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2021 | 40 | 0.190 |
Why?
| Liver Glycogen | 1 | 2021 | 19 | 0.190 |
Why?
| Sunlight | 1 | 2001 | 57 | 0.190 |
Why?
| Apolipoproteins E | 1 | 2021 | 80 | 0.190 |
Why?
| Linoleic Acid | 1 | 2021 | 38 | 0.190 |
Why?
| Lactones | 1 | 2021 | 54 | 0.190 |
Why?
| Transcription Factors | 2 | 2019 | 1531 | 0.190 |
Why?
| Registries | 9 | 2019 | 1763 | 0.190 |
Why?
| Health Status | 2 | 2023 | 722 | 0.190 |
Why?
| Protein Phosphatase 1 | 1 | 2021 | 28 | 0.190 |
Why?
| Arthralgia | 1 | 2021 | 50 | 0.190 |
Why?
| Specimen Handling | 1 | 2002 | 155 | 0.180 |
Why?
| Lod Score | 7 | 2017 | 65 | 0.180 |
Why?
| Glycogen Storage Disease | 1 | 2021 | 20 | 0.180 |
Why?
| Fatty Liver | 3 | 2013 | 217 | 0.180 |
Why?
| Iodide Peroxidase | 1 | 2020 | 27 | 0.180 |
Why?
| Prediabetic State | 3 | 2012 | 224 | 0.180 |
Why?
| Origin of Life | 1 | 2020 | 9 | 0.180 |
Why?
| Models, Genetic | 5 | 2017 | 566 | 0.180 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 8 | 0.180 |
Why?
| Isotopes | 1 | 2020 | 27 | 0.180 |
Why?
| Reproducibility of Results | 8 | 2018 | 2799 | 0.180 |
Why?
| Mental Recall | 4 | 2017 | 170 | 0.170 |
Why?
| Interleukin-8 | 1 | 2021 | 238 | 0.170 |
Why?
| Iron | 2 | 2023 | 234 | 0.170 |
Why?
| Peroxidase | 1 | 2020 | 157 | 0.170 |
Why?
| Parents | 2 | 2007 | 1189 | 0.170 |
Why?
| Aged, 80 and over | 15 | 2019 | 6357 | 0.170 |
Why?
| Self Report | 2 | 2022 | 698 | 0.170 |
Why?
| Gastroenteritis | 2 | 2019 | 65 | 0.170 |
Why?
| Toll-Like Receptors | 1 | 2020 | 166 | 0.170 |
Why?
| Survival Analysis | 4 | 2017 | 1211 | 0.170 |
Why?
| Linear Models | 3 | 2019 | 776 | 0.170 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 106 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 474 | 0.170 |
Why?
| Endocrinology | 1 | 2020 | 69 | 0.170 |
Why?
| Antigens, Viral | 2 | 2019 | 176 | 0.160 |
Why?
| Histones | 2 | 2021 | 535 | 0.160 |
Why?
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 24 | 0.160 |
Why?
| HLA-D Antigens | 2 | 2017 | 34 | 0.160 |
Why?
| Subcutaneous Fat | 5 | 2010 | 71 | 0.160 |
Why?
| Interleukin-1beta | 1 | 2021 | 370 | 0.160 |
Why?
| Health | 2 | 2013 | 74 | 0.160 |
Why?
| Herpesvirus 4, Human | 1 | 2019 | 125 | 0.160 |
Why?
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 83 | 0.160 |
Why?
| Antibodies | 3 | 2011 | 372 | 0.160 |
Why?
| Arthritis, Experimental | 1 | 2020 | 132 | 0.160 |
Why?
| Gestational Age | 4 | 2020 | 758 | 0.150 |
Why?
| Sensitivity and Specificity | 5 | 2015 | 1715 | 0.150 |
Why?
| Interleukins | 1 | 2020 | 236 | 0.150 |
Why?
| Chromatography, Liquid | 1 | 2019 | 348 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 138 | 0.150 |
Why?
| Consensus | 1 | 2020 | 534 | 0.150 |
Why?
| Monocytes | 1 | 2020 | 503 | 0.150 |
Why?
| Mucous Membrane | 1 | 2018 | 108 | 0.150 |
Why?
| Enterovirus Infections | 3 | 2010 | 160 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 256 | 0.150 |
Why?
| Collagen | 1 | 2020 | 416 | 0.150 |
Why?
| Niacin | 1 | 2017 | 18 | 0.150 |
Why?
| Retrospective Studies | 13 | 2022 | 12547 | 0.150 |
Why?
| Maternal Age | 3 | 2004 | 117 | 0.150 |
Why?
| Bone Density | 1 | 2021 | 432 | 0.150 |
Why?
| Mothers | 4 | 2018 | 651 | 0.140 |
Why?
| Oxidative Stress | 1 | 2003 | 1085 | 0.140 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1081 | 0.140 |
Why?
| Myocardial Infarction | 2 | 2021 | 930 | 0.140 |
Why?
| Calcium | 1 | 2023 | 1104 | 0.140 |
Why?
| Algorithms | 2 | 2023 | 1488 | 0.140 |
Why?
| Sweden | 4 | 2018 | 65 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2020 | 385 | 0.140 |
Why?
| Eicosapentaenoic Acid | 2 | 2013 | 28 | 0.140 |
Why?
| Germany | 4 | 2018 | 85 | 0.140 |
Why?
| Immunity, Innate | 1 | 2022 | 723 | 0.140 |
Why?
| Tomography, X-Ray Computed | 9 | 2017 | 2341 | 0.140 |
Why?
| NFI Transcription Factors | 1 | 2016 | 5 | 0.140 |
Why?
| Respiratory Tract Infections | 2 | 2019 | 321 | 0.140 |
Why?
| Regression Analysis | 7 | 2017 | 948 | 0.140 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 370 | 0.140 |
Why?
| Laminin | 1 | 2016 | 69 | 0.140 |
Why?
| Databases, Factual | 2 | 2018 | 1132 | 0.140 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 1729 | 0.130 |
Why?
| Plasma Cells | 1 | 2016 | 57 | 0.130 |
Why?
| Complement System Proteins | 1 | 2019 | 285 | 0.130 |
Why?
| Prenatal Care | 2 | 2017 | 254 | 0.130 |
Why?
| Prevalence | 5 | 2017 | 2255 | 0.130 |
Why?
| Hydrolases | 2 | 2021 | 51 | 0.130 |
Why?
| Microsatellite Repeats | 2 | 2014 | 137 | 0.130 |
Why?
| Adipogenesis | 1 | 2016 | 42 | 0.130 |
Why?
| Niacinamide | 1 | 2016 | 62 | 0.130 |
Why?
| Umbilical Cord | 1 | 2016 | 80 | 0.130 |
Why?
| Diet, High-Fat | 1 | 2017 | 225 | 0.130 |
Why?
| Haplotypes | 6 | 2008 | 455 | 0.130 |
Why?
| Isocitrate Dehydrogenase | 1 | 2015 | 38 | 0.130 |
Why?
| Predictive Value of Tests | 9 | 2018 | 1812 | 0.130 |
Why?
| Environment | 3 | 2019 | 335 | 0.130 |
Why?
| Arthritis | 1 | 2016 | 111 | 0.130 |
Why?
| Interleukin-2 | 2 | 2016 | 415 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 40 | 0.120 |
Why?
| Metabolome | 1 | 2018 | 285 | 0.120 |
Why?
| Early Diagnosis | 4 | 2019 | 218 | 0.120 |
Why?
| Mental Health | 1 | 2020 | 559 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 26 | 0.120 |
Why?
| Hydrocarbons, Chlorinated | 1 | 2014 | 20 | 0.120 |
Why?
| Minority Groups | 3 | 2011 | 228 | 0.120 |
Why?
| Self Disclosure | 2 | 2007 | 59 | 0.120 |
Why?
| Gene-Environment Interaction | 4 | 2018 | 185 | 0.120 |
Why?
| Vaccination | 1 | 2022 | 1205 | 0.120 |
Why?
| Pesticides | 1 | 2014 | 49 | 0.120 |
Why?
| Serum Albumin, Bovine | 1 | 1994 | 62 | 0.120 |
Why?
| Liver | 5 | 2023 | 1681 | 0.120 |
Why?
| Beverages | 1 | 2014 | 60 | 0.120 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 386 | 0.110 |
Why?
| Siblings | 3 | 2010 | 224 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 496 | 0.110 |
Why?
| Severity of Illness Index | 3 | 2019 | 2551 | 0.110 |
Why?
| Finland | 3 | 2018 | 69 | 0.110 |
Why?
| Immunoglobulins | 2 | 2015 | 143 | 0.110 |
Why?
| Asthma | 2 | 2023 | 2051 | 0.110 |
Why?
| Geographic Information Systems | 1 | 2013 | 37 | 0.110 |
Why?
| Quality of Life | 2 | 2020 | 2359 | 0.110 |
Why?
| Interleukin-9 | 1 | 2012 | 10 | 0.100 |
Why?
| Genes, MHC Class II | 1 | 2012 | 70 | 0.100 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1398 | 0.100 |
Why?
| Chromosomes, Human, Pair 3 | 3 | 2010 | 49 | 0.100 |
Why?
| Tuberculosis, Bovine | 1 | 2012 | 3 | 0.100 |
Why?
| Cell Membrane | 1 | 2016 | 681 | 0.100 |
Why?
| Alcohol Drinking | 1 | 2018 | 655 | 0.100 |
Why?
| Patient Compliance | 2 | 2015 | 524 | 0.100 |
Why?
| Epistasis, Genetic | 3 | 2020 | 67 | 0.100 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 140 | 0.100 |
Why?
| Child of Impaired Parents | 1 | 2012 | 40 | 0.100 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.100 |
Why?
| HLA-DRB1 Chains | 3 | 2012 | 98 | 0.100 |
Why?
| Body Fat Distribution | 2 | 2013 | 44 | 0.100 |
Why?
| Bronchial Diseases | 1 | 2011 | 38 | 0.100 |
Why?
| Fatty Acids, Nonesterified | 1 | 2012 | 151 | 0.100 |
Why?
| Particulate Matter | 1 | 2013 | 185 | 0.100 |
Why?
| Vegetables | 2 | 2013 | 133 | 0.100 |
Why?
| Histocompatibility Testing | 3 | 2007 | 116 | 0.100 |
Why?
| Environmental Monitoring | 1 | 2013 | 254 | 0.090 |
Why?
| Mice | 3 | 2022 | 14927 | 0.090 |
Why?
| Triticum | 1 | 2010 | 9 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 498 | 0.090 |
Why?
| Liver Cirrhosis | 2 | 2023 | 235 | 0.090 |
Why?
| Plant Proteins | 1 | 2011 | 81 | 0.090 |
Why?
| Peptide Fragments | 1 | 1994 | 668 | 0.090 |
Why?
| Statistics, Nonparametric | 2 | 2010 | 387 | 0.090 |
Why?
| Health Fairs | 1 | 2009 | 9 | 0.090 |
Why?
| DNA Primers | 3 | 2007 | 514 | 0.090 |
Why?
| Synovitis | 1 | 2009 | 24 | 0.090 |
Why?
| Chromosomes, Human, Pair 1 | 3 | 2004 | 67 | 0.080 |
Why?
| Gliadin | 1 | 2009 | 12 | 0.080 |
Why?
| Cholera Toxin | 1 | 2009 | 27 | 0.080 |
Why?
| Decision Support Techniques | 1 | 2013 | 351 | 0.080 |
Why?
| Biopsy | 3 | 2015 | 1046 | 0.080 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.080 |
Why?
| I-kappa B Proteins | 1 | 2009 | 78 | 0.080 |
Why?
| Haptoglobins | 1 | 2009 | 47 | 0.080 |
Why?
| Receptors, Somatostatin | 1 | 2009 | 24 | 0.080 |
Why?
| Milk, Human | 1 | 2010 | 128 | 0.080 |
Why?
| Intestinal Absorption | 1 | 2009 | 93 | 0.080 |
Why?
| Antigens, CD | 2 | 2009 | 441 | 0.080 |
Why?
| Interferon-gamma | 1 | 2012 | 723 | 0.080 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 17 | 0.080 |
Why?
| Rheumatology | 1 | 2010 | 89 | 0.080 |
Why?
| Hypoglycemic Agents | 2 | 2015 | 1006 | 0.080 |
Why?
| Nutrition Assessment | 3 | 2017 | 74 | 0.080 |
Why?
| Seasons | 4 | 2019 | 448 | 0.080 |
Why?
| Protein Precursors | 1 | 2009 | 119 | 0.080 |
Why?
| Immunization | 2 | 2022 | 400 | 0.080 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 9 | 0.080 |
Why?
| Artificial Intelligence | 1 | 2010 | 145 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2010 | 169 | 0.080 |
Why?
| Antirheumatic Agents | 2 | 2015 | 255 | 0.080 |
Why?
| Permeability | 1 | 2008 | 148 | 0.080 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2023 | 22 | 0.080 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.080 |
Why?
| Organ Specificity | 2 | 2019 | 270 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2012 | 496 | 0.080 |
Why?
| TCF Transcription Factors | 1 | 2007 | 20 | 0.070 |
Why?
| Diabetic Ketoacidosis | 1 | 2009 | 159 | 0.070 |
Why?
| HLA-DP Antigens | 1 | 2007 | 32 | 0.070 |
Why?
| Seafood | 1 | 2007 | 16 | 0.070 |
Why?
| gamma-Glutamyltransferase | 2 | 2019 | 42 | 0.070 |
Why?
| Genotyping Techniques | 2 | 2017 | 69 | 0.070 |
Why?
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2007 | 42 | 0.070 |
Why?
| Influenza, Human | 1 | 2012 | 546 | 0.070 |
Why?
| Carotenoids | 1 | 2007 | 35 | 0.070 |
Why?
| Fluorescent Antibody Technique | 2 | 2020 | 396 | 0.070 |
Why?
| Mutation | 1 | 2017 | 3350 | 0.070 |
Why?
| Rotavirus | 1 | 2006 | 22 | 0.070 |
Why?
| Plethysmography | 2 | 2017 | 104 | 0.070 |
Why?
| Delivery, Obstetric | 2 | 2004 | 118 | 0.070 |
Why?
| Cholesterol, LDL | 2 | 2019 | 307 | 0.070 |
Why?
| Societies, Medical | 2 | 2020 | 678 | 0.070 |
Why?
| Weight Gain | 1 | 2009 | 451 | 0.070 |
Why?
| Rotavirus Infections | 1 | 2006 | 50 | 0.070 |
Why?
| Glucose Intolerance | 2 | 2008 | 137 | 0.070 |
Why?
| Amino Acid Substitution | 1 | 2007 | 262 | 0.070 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2006 | 58 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 704 | 0.070 |
Why?
| Polymerase Chain Reaction | 4 | 2016 | 999 | 0.070 |
Why?
| Pro-Opiomelanocortin | 1 | 2005 | 17 | 0.060 |
Why?
| DNA | 2 | 2009 | 1352 | 0.060 |
Why?
| Fibrinogen | 2 | 2019 | 155 | 0.060 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2329 | 0.060 |
Why?
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 4 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 703 | 0.060 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 41 | 0.060 |
Why?
| Genome Components | 1 | 2005 | 2 | 0.060 |
Why?
| Postpartum Period | 2 | 2021 | 277 | 0.060 |
Why?
| Codon | 1 | 2005 | 86 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 814 | 0.060 |
Why?
| Aging | 2 | 2009 | 1624 | 0.060 |
Why?
| Sleep | 1 | 2010 | 631 | 0.060 |
Why?
| Amino Acid Sequence | 3 | 1999 | 1990 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 42 | 0.060 |
Why?
| Gastrointestinal Diseases | 2 | 2019 | 182 | 0.060 |
Why?
| Albuminuria | 1 | 2005 | 164 | 0.060 |
Why?
| Intestine, Small | 1 | 2005 | 122 | 0.060 |
Why?
| Likelihood Functions | 3 | 2012 | 126 | 0.060 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 323 | 0.060 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2004 | 44 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 13 | 0.060 |
Why?
| Sequence Analysis, DNA | 2 | 2017 | 728 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 94 | 0.060 |
Why?
| Radiography | 3 | 2013 | 827 | 0.060 |
Why?
| Acyltransferases | 1 | 2023 | 46 | 0.060 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 349 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 19 | 0.050 |
Why?
| Transforming Growth Factor beta | 2 | 2022 | 448 | 0.050 |
Why?
| Abdomen | 1 | 2003 | 104 | 0.050 |
Why?
| Proteins | 1 | 2009 | 915 | 0.050 |
Why?
| Protein Tyrosine Phosphatases | 3 | 2004 | 147 | 0.050 |
Why?
| Urban Health | 2 | 2006 | 73 | 0.050 |
Why?
| Glutamates | 1 | 2023 | 58 | 0.050 |
Why?
| Income | 1 | 2003 | 167 | 0.050 |
Why?
| Nutrition Surveys | 2 | 2014 | 224 | 0.050 |
Why?
| Nerve Tissue Proteins | 2 | 2019 | 529 | 0.050 |
Why?
| Nitrates | 1 | 1992 | 72 | 0.050 |
Why?
| Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| Water Supply | 1 | 1992 | 70 | 0.050 |
Why?
| Epidemiologic Studies | 1 | 2021 | 57 | 0.050 |
Why?
| Pseudomonas Infections | 1 | 2003 | 186 | 0.050 |
Why?
| Selection Bias | 1 | 2021 | 33 | 0.050 |
Why?
| Immunization Schedule | 1 | 2022 | 184 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 8 | 0.050 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 921 | 0.050 |
Why?
| Immunoglobulin D | 1 | 2021 | 27 | 0.050 |
Why?
| Serologic Tests | 1 | 2021 | 49 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 78 | 0.050 |
Why?
| Waist Circumference | 2 | 2013 | 123 | 0.050 |
Why?
| Electrochemical Techniques | 1 | 2021 | 45 | 0.040 |
Why?
| Financial Management | 1 | 2020 | 15 | 0.040 |
Why?
| Probability | 1 | 2021 | 289 | 0.040 |
Why?
| Asymptomatic Diseases | 1 | 2021 | 75 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 96 | 0.040 |
Why?
| Synovial Fluid | 1 | 2020 | 57 | 0.040 |
Why?
| Residence Characteristics | 2 | 2019 | 275 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 297 | 0.040 |
Why?
| Databases, Genetic | 1 | 2021 | 206 | 0.040 |
Why?
| Energy Metabolism | 2 | 2018 | 729 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 10 | 0.040 |
Why?
| Mannose | 1 | 2019 | 21 | 0.040 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 287 | 0.040 |
Why?
| Immunophenotyping | 1 | 2020 | 276 | 0.040 |
Why?
| Laryngitis | 1 | 2019 | 3 | 0.040 |
Why?
| Body Weight | 2 | 2017 | 873 | 0.040 |
Why?
| Norway | 1 | 2019 | 36 | 0.040 |
Why?
| Health Equity | 1 | 2020 | 53 | 0.040 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 81 | 0.040 |
Why?
| Sequence Homology | 1 | 1999 | 39 | 0.040 |
Why?
| Conjunctivitis | 1 | 2019 | 17 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 323 | 0.040 |
Why?
| Health Plan Implementation | 1 | 2020 | 132 | 0.040 |
Why?
| Butyrates | 1 | 2019 | 53 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 69 | 0.040 |
Why?
| LIM-Homeodomain Proteins | 1 | 2019 | 14 | 0.040 |
Why?
| Methotrexate | 1 | 2020 | 227 | 0.040 |
Why?
| Brazil | 1 | 2019 | 92 | 0.040 |
Why?
| Outpatients | 1 | 1992 | 328 | 0.040 |
Why?
| Hospitalization | 2 | 2004 | 1754 | 0.040 |
Why?
| Powders | 1 | 2018 | 38 | 0.040 |
Why?
| Health Services | 1 | 1999 | 103 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 101 | 0.040 |
Why?
| Fever | 1 | 2019 | 280 | 0.040 |
Why?
| Small-Area Analysis | 1 | 1997 | 8 | 0.040 |
Why?
| Forecasting | 1 | 2019 | 332 | 0.040 |
Why?
| Multiple Trauma | 1 | 1998 | 90 | 0.040 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 174 | 0.040 |
Why?
| Diastole | 1 | 2018 | 131 | 0.040 |
Why?
| Community Health Planning | 1 | 1997 | 44 | 0.040 |
Why?
| Systole | 1 | 2018 | 171 | 0.040 |
Why?
| Multiple Organ Failure | 1 | 1998 | 142 | 0.040 |
Why?
| Whooping Cough | 1 | 1997 | 49 | 0.040 |
Why?
| Discriminant Analysis | 1 | 2017 | 38 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 2019 | 205 | 0.040 |
Why?
| Health Planning | 1 | 1997 | 46 | 0.040 |
Why?
| Pilot Projects | 1 | 2002 | 1375 | 0.040 |
Why?
| Otitis Media | 1 | 2019 | 142 | 0.040 |
Why?
| Muscle Proteins | 1 | 2019 | 210 | 0.040 |
Why?
| Cholesterol | 1 | 2019 | 368 | 0.040 |
Why?
| Insurance, Health | 1 | 1999 | 244 | 0.040 |
Why?
| Blood Group Antigens | 1 | 1997 | 14 | 0.040 |
Why?
| CTLA-4 Antigen | 2 | 2009 | 78 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 331 | 0.040 |
Why?
| DNA Mutational Analysis | 2 | 2010 | 372 | 0.040 |
Why?
| Genes, Immunoglobulin Light Chain | 1 | 2016 | 6 | 0.030 |
Why?
| Genes, Immunoglobulin Heavy Chain | 1 | 2016 | 10 | 0.030 |
Why?
| Phosphofructokinase-2 | 1 | 2016 | 14 | 0.030 |
Why?
| Acute Disease | 1 | 2019 | 915 | 0.030 |
Why?
| Diabetes Complications | 1 | 2018 | 212 | 0.030 |
Why?
| Data Collection | 1 | 2019 | 623 | 0.030 |
Why?
| Antibody Formation | 1 | 2018 | 267 | 0.030 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 63 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 69 | 0.030 |
Why?
| Models, Biological | 2 | 2019 | 1636 | 0.030 |
Why?
| Complement Activation | 1 | 2019 | 340 | 0.030 |
Why?
| Th17 Cells | 1 | 2016 | 59 | 0.030 |
Why?
| Sirtuin 1 | 1 | 2016 | 29 | 0.030 |
Why?
| Los Angeles | 2 | 2008 | 56 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2021 | 436 | 0.030 |
Why?
| Enterovirus | 1 | 1997 | 72 | 0.030 |
Why?
| Mortality | 2 | 2007 | 287 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 676 | 0.030 |
Why?
| Infant Mortality | 1 | 1996 | 91 | 0.030 |
Why?
| Protein Isoforms | 1 | 2017 | 339 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 617 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 1997 | 183 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2020 | 474 | 0.030 |
Why?
| Georgia | 1 | 2015 | 62 | 0.030 |
Why?
| Florida | 1 | 2015 | 73 | 0.030 |
Why?
| Symptom Assessment | 1 | 2016 | 118 | 0.030 |
Why?
| Synovial Membrane | 1 | 2015 | 75 | 0.030 |
Why?
| Australia | 1 | 1996 | 206 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Erythrocyte Count | 1 | 2014 | 19 | 0.030 |
Why?
| North America | 1 | 1996 | 259 | 0.030 |
Why?
| Washington | 1 | 2015 | 133 | 0.030 |
Why?
| Databases, Nucleic Acid | 1 | 2014 | 31 | 0.030 |
Why?
| Blood Proteins | 1 | 1997 | 233 | 0.030 |
Why?
| Solubility | 1 | 2015 | 224 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 85 | 0.030 |
Why?
| Rituximab | 1 | 2015 | 150 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2015 | 77 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 71 | 0.030 |
Why?
| Datasets as Topic | 1 | 2014 | 98 | 0.030 |
Why?
| Biomedical Research | 1 | 2020 | 585 | 0.030 |
Why?
| Isoenzymes | 2 | 2006 | 286 | 0.030 |
Why?
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| Apolipoproteins | 1 | 2014 | 36 | 0.030 |
Why?
| Leukocyte Count | 1 | 2014 | 292 | 0.030 |
Why?
| Treatment Outcome | 2 | 2004 | 9122 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 151 | 0.030 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 60 | 0.030 |
Why?
| Lipoproteins, HDL | 1 | 2014 | 76 | 0.030 |
Why?
| Birth Order | 2 | 2004 | 12 | 0.030 |
Why?
| Neurocan | 1 | 2013 | 1 | 0.030 |
Why?
| Cystic Fibrosis | 1 | 2003 | 957 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 2 | 2008 | 353 | 0.030 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 9 | 0.030 |
Why?
| Plant Roots | 1 | 2013 | 35 | 0.030 |
Why?
| Lysophospholipase | 1 | 2013 | 11 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 441 | 0.030 |
Why?
| Lectins, C-Type | 1 | 2013 | 61 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 181 | 0.030 |
Why?
| Amino Acids, Branched-Chain | 1 | 2013 | 32 | 0.030 |
Why?
| Fetal Development | 1 | 2016 | 247 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2013 | 64 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1997 | 2796 | 0.030 |
Why?
| Public Health | 1 | 2017 | 435 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 691 | 0.030 |
Why?
| Promoter Regions, Genetic | 2 | 2009 | 1133 | 0.030 |
Why?
| Lung | 2 | 2017 | 3595 | 0.030 |
Why?
| HLA-DR2 Antigen | 1 | 2012 | 8 | 0.030 |
Why?
| Culture | 1 | 2013 | 122 | 0.030 |
Why?
| Hemoglobins | 1 | 2014 | 315 | 0.030 |
Why?
| Fruit | 1 | 2013 | 127 | 0.030 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 68 | 0.030 |
Why?
| Antigens | 1 | 1994 | 318 | 0.030 |
Why?
| Ireland | 1 | 2012 | 24 | 0.030 |
Why?
| Intestines | 1 | 2015 | 322 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2012 | 76 | 0.030 |
Why?
| Genome | 1 | 2014 | 271 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 746 | 0.030 |
Why?
| Models, Statistical | 2 | 2009 | 602 | 0.030 |
Why?
| Tuberculin Test | 1 | 2012 | 32 | 0.030 |
Why?
| Sentinel Surveillance | 1 | 2012 | 38 | 0.030 |
Why?
| Arthrography | 1 | 2011 | 22 | 0.020 |
Why?
| Academic Medical Centers | 1 | 1994 | 412 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1177 | 0.020 |
Why?
| Solvents | 1 | 2012 | 104 | 0.020 |
Why?
| ROC Curve | 1 | 2013 | 447 | 0.020 |
Why?
| Anxiety Disorders | 1 | 1994 | 307 | 0.020 |
Why?
| Silicon Dioxide | 1 | 2012 | 89 | 0.020 |
Why?
| Child Abuse | 1 | 1996 | 451 | 0.020 |
Why?
| Indians, North American | 1 | 1997 | 570 | 0.020 |
Why?
| Leptin | 1 | 2012 | 211 | 0.020 |
Why?
| Dyslipidemias | 1 | 2013 | 154 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 1857 | 0.020 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2015 | 497 | 0.020 |
Why?
| Women's Health | 1 | 2013 | 271 | 0.020 |
Why?
| Congresses as Topic | 1 | 2012 | 198 | 0.020 |
Why?
| Diabetic Angiopathies | 1 | 2012 | 244 | 0.020 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2009 | 52 | 0.020 |
Why?
| Obesity, Abdominal | 1 | 2010 | 38 | 0.020 |
Why?
| Sample Size | 1 | 2010 | 112 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2012 | 368 | 0.020 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.020 |
Why?
| Actuarial Analysis | 1 | 1989 | 21 | 0.020 |
Why?
| Maternal Exposure | 1 | 2011 | 138 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2009 | 89 | 0.020 |
Why?
| Wounds and Injuries | 1 | 1996 | 723 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.020 |
Why?
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 7 | 0.020 |
Why?
| Disease | 1 | 2010 | 86 | 0.020 |
Why?
| Southwestern United States | 1 | 2009 | 91 | 0.020 |
Why?
| Body Weights and Measures | 1 | 2008 | 33 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 24 | 0.020 |
Why?
| Health Surveys | 1 | 2010 | 443 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2017 | 4718 | 0.020 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 12 | 0.020 |
Why?
| Sleep Deprivation | 1 | 2010 | 166 | 0.020 |
Why?
| Sex Distribution | 1 | 2008 | 335 | 0.020 |
Why?
| Reference Values | 2 | 1999 | 748 | 0.020 |
Why?
| Survival | 1 | 2007 | 37 | 0.020 |
Why?
| Spleen | 1 | 2009 | 486 | 0.020 |
Why?
| Cause of Death | 1 | 1989 | 364 | 0.020 |
Why?
| RNA, Viral | 1 | 2010 | 567 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 941 | 0.020 |
Why?
| HLA-DP beta-Chains | 1 | 2007 | 76 | 0.020 |
Why?
| Urban Population | 1 | 2009 | 401 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 44 | 0.020 |
Why?
| Base Sequence | 1 | 2010 | 2119 | 0.020 |
Why?
| Rural Health | 1 | 2006 | 67 | 0.020 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| Subcutaneous Fat, Abdominal | 1 | 2005 | 13 | 0.020 |
Why?
| Rural Population | 1 | 2009 | 446 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 79 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 1423 | 0.020 |
Why?
| Albumins | 1 | 2005 | 89 | 0.020 |
Why?
| Interleukin-13 | 1 | 2005 | 123 | 0.020 |
Why?
| Open Reading Frames | 1 | 2005 | 116 | 0.020 |
Why?
| Primary Health Care | 1 | 1994 | 1512 | 0.010 |
Why?
| Interleukin-4 | 1 | 2005 | 209 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2005 | 133 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 642 | 0.010 |
Why?
| Pancreatitis | 1 | 2005 | 107 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 109 | 0.010 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2003 | 16 | 0.010 |
Why?
| Models, Theoretical | 1 | 2008 | 517 | 0.010 |
Why?
| Growth | 1 | 2004 | 56 | 0.010 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2003 | 24 | 0.010 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2003 | 22 | 0.010 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2003 | 30 | 0.010 |
Why?
| Adult Children | 1 | 2003 | 21 | 0.010 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2003 | 34 | 0.010 |
Why?
| Radioimmunoassay | 1 | 2004 | 163 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 258 | 0.010 |
Why?
| Confidence Intervals | 1 | 2004 | 306 | 0.010 |
Why?
| Creatinine | 1 | 2005 | 425 | 0.010 |
Why?
| Genetics, Population | 1 | 2004 | 190 | 0.010 |
Why?
| Remission Induction | 1 | 2004 | 233 | 0.010 |
Why?
| Transforming Growth Factor beta1 | 1 | 2004 | 154 | 0.010 |
Why?
| Causality | 1 | 2003 | 105 | 0.010 |
Why?
| Monte Carlo Method | 1 | 2003 | 137 | 0.010 |
Why?
| Survival Rate | 1 | 2006 | 1646 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 50 | 0.010 |
Why?
| Epidemiologic Methods | 1 | 1992 | 72 | 0.010 |
Why?
| Neonatal Screening | 1 | 2003 | 152 | 0.010 |
Why?
| Morbidity | 1 | 1992 | 279 | 0.010 |
Why?
| Pseudomonas aeruginosa | 1 | 2003 | 299 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2010 | 3545 | 0.010 |
Why?
| Histocompatibility Antigens Class I | 1 | 2002 | 174 | 0.010 |
Why?
| Double-Blind Method | 1 | 2004 | 1664 | 0.010 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.010 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 25 | 0.010 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 22 | 0.010 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 27 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2004 | 1214 | 0.010 |
Why?
| Capitation Fee | 1 | 1999 | 13 | 0.010 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 46 | 0.010 |
Why?
| Chronic Disease | 1 | 2005 | 1591 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 66 | 0.010 |
Why?
| Office Visits | 1 | 1999 | 79 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 1999 | 83 | 0.010 |
Why?
| Medical Records | 1 | 1999 | 155 | 0.010 |
Why?
| Platelet Count | 1 | 1998 | 83 | 0.010 |
Why?
| APACHE | 1 | 1998 | 59 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 133 | 0.010 |
Why?
| Coronary Artery Disease | 1 | 2004 | 608 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 257 | 0.010 |
Why?
| Fluid Therapy | 1 | 1998 | 121 | 0.010 |
Why?
| Population Density | 1 | 1997 | 94 | 0.010 |
Why?
| Demography | 1 | 1998 | 261 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 65 | 0.010 |
Why?
| Age Distribution | 1 | 1997 | 340 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 309 | 0.010 |
Why?
| Marital Status | 1 | 1996 | 41 | 0.010 |
Why?
| Injury Severity Score | 1 | 1998 | 457 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 219 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 144 | 0.010 |
Why?
| Virus Diseases | 1 | 1998 | 196 | 0.010 |
Why?
| Blood Transfusion | 1 | 1998 | 276 | 0.010 |
Why?
| Marriage | 1 | 1997 | 106 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 383 | 0.010 |
Why?
| Neoplasms | 1 | 1989 | 2106 | 0.010 |
Why?
| Medicaid | 1 | 1999 | 409 | 0.010 |
Why?
| Viral Proteins | 1 | 1997 | 281 | 0.010 |
Why?
| Poverty | 1 | 1997 | 443 | 0.010 |
Why?
| Sex Characteristics | 1 | 1998 | 635 | 0.010 |
Why?
| Skinfold Thickness | 1 | 1992 | 48 | 0.010 |
Why?
| Psychiatric Status Rating Scales | 1 | 1994 | 484 | 0.010 |
Why?
| Emergency Medical Services | 1 | 1999 | 587 | 0.010 |
Why?
| Patient Discharge | 1 | 1997 | 767 | 0.010 |
Why?
| Psychometrics | 1 | 1994 | 608 | 0.010 |
Why?
|
|
Norris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|